JPMorgan Chase & Co. reissued their overweight rating on shares of AstraZeneca (LON:AZN – Free Report) in a report issued on ...

Pomerantz LLP is investigating claims on behalf of investors of  AstraZeneca PLC ("AstraZeneca" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646 ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

We recently compiled a list of the 10 Best UK Stocks to Invest in Now. In this article, we are going to take a look at where ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

Six months after Amgen and AstraZeneca reported promising results for Tezspire (t | A phase 3 study has shown that ...

At the close in Stockholm, the OMX Stockholm 30 lost 1.01%. The best performers of the session on the OMX Stockholm 30 were ...

Fed delivered the widely expected 25 bps rate cut yesterday. A pause in rate cuts can't be ruled out in December. See my ...

AstraZeneca and Amgen's Phase 3 trial data shows Tezspire significantly reduces nasal polyps and congestion in patients with chronic rhinosinusitis with nasal polyps.

Leerink Partners analyst Andrew Berens has maintained their bullish stance on AZN stock, giving a Buy rating on November 6. Andrew ...